Can a phone app replace pills for back pain?

NCT ID NCT07664267

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests a smartphone app called MORA Cure for people with chronic low back pain lasting at least 12 weeks. Half the participants use the app for 8 weeks, while the other half receive standard education and self-exercise materials. The goal is to see if the app reduces pain intensity better than usual care.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
MORA Cure LBP (digital therapeutic app providing exercise and cognitive behavioral therapy)
What this could lead to
If it works, this could offer a convenient, app-based way to reduce chronic low back pain without medication or surgery.
What could go wrong
This is a relatively small trial (156 people) and not yet compared against standard treatments. The app may not work for everyone, and results may not apply to all types of back pain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LOW-BACK PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Chung-Ang University Gwangmyeong Hospital

    Gwangmyeong, Gyeonggi-do, South Korea

  • Hanyang University Guri Hospital

    Guri-si, Gyeonggi-do, South Korea

  • Kangbuk Samsung Hospital

    Seoul, Seoul, South Korea

  • Nowon Eulji University Hospital

    Seoul, Seoul, South Korea

  • Samsung Medical Center

    Seoul, Seoul, South Korea

  • Seoul Asan Hospital

    Seoul, Seoul, South Korea

  • Seoul National University Hospital

    Seoul, Korea, South Korea

  • The Catholic University of Korea Uijeongbu St. Mary's Hospital

    Uijeongbu-si, Gyeonggi-do, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.